Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Accuray Incorporated (ARAY) a Good Buy?

Page 1 of 2

Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren’t very good. However, our research shows this not to be the case. In fact, when it comes to their very top picks collectively, they show a strong ability to pick winning stocks. Between November 1, 2014 and October 30 of this year, less than 49% of the stocks in the S&P 500 beat the market. However, hedge funds’ top 30 stock picks from the index had a much higher success rate than this, at 63%. The returns from these 30 stocks also easily bested the broader market, at 9.5% compared to 5.2%, despite there being a few duds in there like Micron and Anadarko (even their collective wisdom isn’t perfect). The results show that there is plenty of merit to imitating the collective wisdom of top investors.

Accuray Incorporated (NASDAQ:ARAY) was in 20 hedge funds’ portfolios at the end of September. ARAY investors should pay attention to an increase in support from the world’s most elite money managers lately. There were 19 hedge funds in our database with ARAY positions at the end of the previous quarter. At the end of this article we will also compare ARAY to other stocks including Carriage Services, Inc. (NYSE:CSV), Five Prime Therapeutics Inc (NASDAQ:FPRX), and TravelCenters of America LLC (NYSE:TA) to get a better sense of its popularity.

Follow Accuray Inc (NASDAQ:ARAY)
Trade (NASDAQ:ARAY) Now!

Now, we’re going to take a look at the latest action regarding Accuray Incorporated (NASDAQ:ARAY).

What does the smart money think about Accuray Incorporated (NASDAQ:ARAY)?

At Q3’s end, a total of 20 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 5% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Partner Fund Management, managed by Christopher James, holds the biggest position in Accuray Incorporated (NASDAQ:ARAY). Partner Fund Management has a $28.8 million position in the stock, comprising 0.8% of its 13F portfolio. The second most bullish fund manager is Royce & Associates, led by Chuck Royce, holding a $10.8 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Jim Simons’s Renaissance Technologies, D E Shaw and Philip Hempleman’s Ardsley Partners.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!